Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
about
Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2.A human aminoacyl-tRNA synthetase as a regulator of angiogenesisPerlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesisHuman tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrinsCCN3 (NOV) is a novel angiogenic regulator of the CCN protein familyAngiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrinsBeta 3-endonexin, a novel polypeptide that interacts specifically with the cytoplasmic tail of the integrin beta 3 subunitCooperation between integrin alphavbeta3 and VEGFR2 in angiogenesisSpecific interaction of the recombinant disintegrin-like domain of MDC-15 (metargidin, ADAM-15) with integrin alphavbeta3Direct binding of integrin alphavbeta3 to FGF1 plays a role in FGF1 signalingA fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivocDNA cloning reveals two mouse beta5 integrin transcripts distinct in cytoplasmic domains as a result of alternative splicingThe lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1Complex interactions between the laminin alpha 4 subunit and integrins regulate endothelial cell behavior in vitro and angiogenesis in vivo.Transforming growth factor beta induces rosettes of podosomes in primary aortic endothelial cells.Interaction of endostatin with integrins implicated in angiogenesisADAM 23/MDC3, a human disintegrin that promotes cell adhesion via interaction with the alphavbeta3 integrin through an RGD-independent mechanismEndothelial integrins and angiogenesis: not so simple anymoreFisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivoHuman cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?A heterotypic bystander effect for tumor cell killing after adeno-associated virus/phage-mediated, vascular-targeted suicide gene transferCYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growthTumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancerHomeobox B3 promotes capillary morphogenesis and angiogenesisPhosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cellsAn RGD sequence in the P2Y(2) receptor interacts with alpha(V)beta(3) integrins and is required for G(o)-mediated signal transductionThe role of alpha(v)beta(3) in prostate cancer progressionIntegrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesisBiological response modifiers in cancerSuppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculatureNoninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGDSyndecans in tumor cell adhesion and signalingA selective cyclic integrin antagonist blocks the integrin receptors alphavbeta3 and alphavbeta5 and inhibits retinal pigment epithelium cell attachment, migration and invasionAnti-lipid phosphate phosphohydrolase-3 (LPP3) antibody inhibits bFGF- and VEGF-induced capillary morphogenesis of endothelial cellsActivation of nuclear factor kappa B (NF-kappaB) by connective tissue growth factor (CCN2) is involved in sustaining the survival of primary rat hepatic stellate cellsSafety of targeting tumor endothelial cell antigensAntiangiogenic mechanisms and factors in breast cancer treatmentMechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiformeαV integrins in angiogenesis and cancerVon Willebrand factor, angiodysplasia and angiogenesis
P2860
Q22008760-4516659A-CC35-47F9-A5C9-58A70E635791Q24292093-102B1AC2-151D-4F98-95E0-74AFA2A85572Q24295251-FC5D0CFF-9D1E-41C6-AEF8-4BB756E66564Q24299560-8E814469-F7F6-4707-B086-8CC8DB2B923FQ24299868-1CC1155B-8F98-4ED8-8224-FF78C27C6127Q24311459-2D0676A5-9699-44F7-BE05-E99BEB18600BQ24316118-22836B84-0772-4C36-BEAB-539258C53335Q24318607-9B191BD3-664B-4CF4-97BD-EF50250E20A6Q24319074-8D5002F6-3715-4AEE-9D58-35339FF4405AQ24336141-571C592E-13EB-4092-8D57-8C471CD4D140Q24530544-DA1CDE3A-DAFF-4495-8663-EC5084CED2E2Q24530762-3AE0F6CE-F5F3-4FE1-B9C2-078E094D3B66Q24538981-783D1F70-CA19-41AF-874A-CE7C4FCB7C39Q24541488-F7369E1D-7DE4-42AB-AF7B-10ECECD2331EQ24544223-EFE02F4D-3A20-4837-9476-DA344A8655C3Q24545535-F2CE4128-497C-43C1-AEB1-804F8A27E345Q24548850-F7F14A8D-BAE2-47F1-89B9-2CF33DC9AB80Q24553319-9B94D03D-708F-4629-A3CB-013F89CEEFB9Q24554513-54C5A8BE-8BDD-4937-9623-7813F3BF7ECCQ24561702-92847912-74A0-47AA-AEE2-4C48102C4E7FQ24616181-3F61C1EB-F7C5-4A46-B2ED-DC2EBBCE41C3Q24647068-0C3F6949-4533-4516-A6ED-4E068F275DAAQ24650026-0085A796-CE04-4415-A291-F42DCFF87D04Q24670419-9643B0C8-A89F-49D7-B5E6-3B269956F1BBQ24672163-DCB39DE7-D71A-4F70-B4DE-4EB4F0B35097Q24681126-B16DFE76-D640-43F7-B744-52FDFF004F49Q24682923-59FC85D9-B8BC-4D0D-A003-2EFD17E31C85Q24683364-A347CF0B-B573-43E3-8A8F-C84DF22D1582Q24685049-6B3320AE-6D9A-4EC2-9342-DB4323816155Q24799893-14CCE58C-0227-4414-820B-178D7BDD9297Q24805375-F77F1BB7-1F97-47EC-B233-90BCA57951F2Q24807364-BC3A8C2E-8E5A-4AD5-B9A4-20B05FD76E4CQ24812140-F1208859-62B5-4D79-BAAC-271AA243F5FBQ24812333-8BB018C8-DAC4-4533-8FBA-1D0DEE77F207Q24815319-C20AFD99-EF83-4440-80C8-58EA5F99FD20Q26748863-A47A0C85-BE94-42B4-AD63-30DC3CA421A3Q26751226-FEFA2145-5A4E-4027-B5DE-7238D7A54E38Q26824557-E54DCCE8-67B6-4208-A3E3-154839CF9F1FQ26851768-ECAB35F7-5F24-4004-9185-EC174DEE9E6CQ26852889-A65B4AAA-1BBA-4700-85C7-2DFEB598CF93
P2860
Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
description
1994 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1994
@ast
im Dezember 1994 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 30 December 1994)
@en
wetenschappelijk artikel (gepubliceerd op 1994/12/30)
@nl
наукова стаття, опублікована в грудні 1994
@uk
مقالة علمية (نشرت في 30-12-1994)
@ar
name
Integrin alpha v beta 3 antago ...... is of angiogenic blood vessels
@ast
Integrin alpha v beta 3 antago ...... is of angiogenic blood vessels
@en
type
label
Integrin alpha v beta 3 antago ...... is of angiogenic blood vessels
@ast
Integrin alpha v beta 3 antago ...... is of angiogenic blood vessels
@en
prefLabel
Integrin alpha v beta 3 antago ...... is of angiogenic blood vessels
@ast
Integrin alpha v beta 3 antago ...... is of angiogenic blood vessels
@en
P2093
P3181
P1433
P1476
Integrin alpha v beta 3 antago ...... is of angiogenic blood vessels
@en
P2093
Cheresh DA
Montgomery AM
Reisfeld RA
Rosenfeld M
P304
P3181
P356
10.1016/0092-8674(94)90007-8
P407
P577
1994-12-30T00:00:00Z